Provironus 25 mg Driada Medical

Description

Provironus 25 mg Driada Medical — mesterolone from Driada Medical at 25 mg. Oral DHT derivative without 17α-alkyl toxicity. Strong SHBG displacement frees bound testosterone — a cycle adjunct rather than standalone anabolic.

Key Benefits

• DHT-class oral — SHBG reducer and libido support
• Mild anti-estrogen by AR competition at the breast tissue
• Does not suppress HPTA at typical doses — can be run year-round
• No aromatisation, minimal liver load despite 17α-methylation
• On-cycle auxiliary, not a mass-builder
• Each unit dosed at 25 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: 25–75 mg/day, split 2–3×. Cycle with compounds that benefit from reduced SHBG (testosterone-based stacks). Can run for full cycle duration (12+ weeks) due to mild profile.

How It Works

17α-methyl DHT (proviron). Binds the AR weakly but has high SHBG affinity — the primary on-cycle benefit is freeing bound testosterone. Does not aromatise. Mild anti-estrogenic effect via AR competition in breast tissue. Androgenic but not mass-building.

Pharmacokinetics

Plasma half-life approximately 12 hours. Twice-daily dosing smooths serum. Hepatotoxic profile milder than most 17α-methylated orals — ALT/AST at week 6 still standard.

Potential Side Effects

Signature improvements: libido restoration on cycle, denser muscle feel. Side-effect profile mild. Hair-thinning risk in susceptible users. Minimal HPTA impact — not a PCT compound, but not a suppressant either.

Cycle & Stacking Guide

Run alongside any testosterone-based cycle at 25–50 mg/day for on-cycle libido and SHBG management. Stacks with cutting protocols (test + mesterolone + clen/var) for harder look. Not a standalone compound.

Manufacturer Notes

Driada Medical positions itself at the affordable end of the market while maintaining third-party lab verification. Their vial caps carry a tamper-seal date code.

Storage & Handling

Store in the original blister or bottle at 15–25 °C, away from direct sunlight, heat, and humidity. Oral preparations lose potency faster if exposed to moisture; keep the desiccant (if included) with the tablets. Keep out of reach of children. For research and educational purposes only.